Prevention of breast cancer skeletal metastases with parathyroid hormone

Advanced breast cancer is frequently associated with skeletal metastases and accelerated bone loss. Recombinant parathyroid hormone [teriparatide, PTH(1-34)] is the first anabolic agent approved in the US for treatment of osteoporosis. While signaling through the PTH receptor in the osteoblast linea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Swami, Srilatha, Johnson, Joshua, Bettinson, Lance A., Kimura, Takaharu, Zhu, Hui, Albertelli, Megan A., Johnson, Rachelle W., Wu, Joy Y.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5621896/
https://ncbi.nlm.nih.gov/pubmed/28878134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.90874
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados